Transformation of lymphocytes from patients with multiple sclerosis. Use of encephalitogen of human origin, with a report of a trial of immunosuppressive therapy in multiple sclerosis.
D000328:Adult; D000368:Aged; D000818:Animals; D000941:Antigens / Q000627:therapeutic use; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D037102:Lectins / Q000627:therapeutic use; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008459:Measles virus; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy; D011506:Proteins / Q000627:therapeutic use; D012136:Respiratory Syncytial Viruses
D000941:Antigens; D007166:Immunosuppressive Agents; D037102:Lectins; D011506:Proteins